You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

contiguous stage II adult diffuse mixed cell lymphoma

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Composite Lymphoma, Grade 3b Follicular Lymphoma, Stage I DLBCL Trial in Seattle (drug, other, biological)

Completed
Has Results
  • Composite Lymphoma
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 22, 2020

Lymphoma Trial in Germany, Switzerland (biological, drug, radiation)

Completed
  • Lymphoma
  • filgrastim
  • +7 more
  • Aachen, Germany
  • +174 more
May 14, 2021

Lymphoma Trial in Germany, Israel, Italy (rituximab, cyclophosphamide, doxorubicin HCl)

Completed
  • Lymphoma
  • rituximab
  • +4 more
  • Aachen, Germany
  • +77 more
Mar 9, 2021

Lymphoma Trial in Germany, Israel (biological, drug, radiation)

Completed
  • Lymphoma
  • filgrastim
  • +6 more
  • Amberg, Germany
  • +78 more
Mar 9, 2021

Lymphoma Trial in Canada, United States (biological, drug, procedure, radiation)

Completed
Has Results
  • Lymphoma
  • rituximab
  • +10 more
  • Portland, Oregon
  • +14 more
Jan 29, 2021

Recurrent DLBCL, Recurrent Grade 3b Follicular Lymphoma, Recurrent High Grade B-Cell Lymphoma Trial in Duarte (Biopsy,

Not yet recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +11 more
  • Biopsy
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +18 more
  • Scottsdale, Arizona
  • +1 more
Sep 28, 2020

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)

Terminated
  • Non-Hodgkin's Lymphoma
  • +5 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Dec 14, 2020

Non Hodgkin Lymphoma Trial in United Kingdom (R-CHOP + acalabrutinib)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • R-CHOP + acalabrutinib
  • Southampton, Hampshire, United Kingdom
  • +6 more
Oct 26, 2022

Diffuse Large B-cell Lymphoma Trial in Worldwide (MB-CART2019.1, R-GemOx or BR plus polatuzumab vedotin)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • MB-CART2019.1
  • R-GemOx or BR plus polatuzumab vedotin
  • Graz, Austria
  • +55 more
Jan 5, 2023

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

Terminated
Has Results
  • Adenocarcinoma of the Esophagus
  • +13 more
  • oblimersen sodium
  • +2 more
  • Bronx, New York
    Montefiore Medical Center
Jan 29, 2021

Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in Boston (Copanlisib, Venetoclax)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Duarte, California
  • +2 more
Nov 10, 2022

Hematological Malignancies - SANGUINE

Recruiting
  • Hematologic Malignancy
  • Blood sampling for HemaChip screening/diagnostic testing
  • Bone marrow sampling
  • Olomouc, Czechia
  • +3 more
Feb 9, 2023

Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in Los Angeles (tumor lysate-pulsed autologous

Completed
Has Results
  • Adult Diffuse Astrocytoma
  • +4 more
  • tumor lysate-pulsed autologous dendritic cell vaccine
  • laboratory biomarker analysis
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Oct 14, 2020

Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood

Active, not recruiting
Has Results
  • Adult T Acute Lymphoblastic Leukemia
  • +7 more
  • Birmingham, Alabama
  • +211 more
Jan 26, 2022

EBV-induced Lymphomas, EBV-associated Malignancies, Transplant Patients With EBV Viremia at High Risk of Developing a Recurrent

Completed
  • EBV-induced Lymphomas
  • +2 more
  • allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2020

Lymphoma, Non-Hodgkin Trial in Worldwide (RO7227166, Obinutuzumab, Glofitamab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Pasadena, California
  • +14 more
Jan 30, 2023

Lymphoma, Large B-Cell, Diffuse, Stage III Follicular Lymphoma Trial in Shanghai (Metformin, Placebos)

Unknown status
  • Lymphoma, Large B-Cell, Diffuse
  • Stage III Follicular Lymphoma
  • Shanghai, China
    Ruijin Hospital
Mar 9, 2020

Anemia, Leukemia, Lymphoma Trial in Los Angeles (darbepoetin alfa, epoetin alfa)

Completed
  • Anemia
  • +6 more
  • darbepoetin alfa
  • epoetin alfa
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020

Diffuse Large B-cell-lymphoma Trial in Saint Louis, Cleveland (Venetoclax, Rituximab, Ifosfamide)

Active, not recruiting
  • Diffuse Large B-cell-lymphoma
  • Saint Louis, Missouri
  • +2 more
Nov 14, 2022

Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in San Francisco (Everolimus, Archival Tissue

Completed
Has Results
  • Adult Diffuse Astrocytoma
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jul 24, 2020

Diffuse Large Cell Lymphoma Relapsed/Refractory Trial in San Francisco (Ofatumumab, Etoposide, Cytarabine)

Completed
Has Results
  • Diffuse Large Cell Lymphoma Relapsed/Refractory
  • San Francisco, California
    University of California, San Francisco
Jun 5, 2022

DLBCL Trial in Worldwide (Epcoritamab, Cyclophosphamide, Rituximab)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Birmingham, Alabama
  • +376 more
Jan 30, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Germany (5-Fluorouracil, Leucovorin, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Aachen, Germany
  • +14 more
Sep 7, 2022

Cervical Cancer, Chronic Myeloproliferative Disorders, Leukemia Trial in Los Angeles (Fragmin, )

Completed
  • Cervical Cancer
  • +8 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020